| MeSH term | MeSH ID | Detail |
|---|---|---|
| Otitis Media | D010033 | 12 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Whooping Cough | D014917 | 6 associated lipids |
| Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 675 references associated with ERYTHROMYCIN ESTOLATE in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for ERYTHROMYCIN ESTOLATE
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
All references with ERYTHROMYCIN ESTOLATE
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Ginsburg CM et al. | Seroepidemiology of the group-A streptococcal carriage state in a private pediatric practice. | 1985 | Am. J. Dis. Child. | pmid:3890522 |
| Howard JE et al. | Otitis media of infancy and early childhood. A double-blind study of four treatment regimens. | 1976 | Am. J. Dis. Child. | pmid:8980 |
| GRIFFITH RS and BLACK HR | COMPARISON OF THE BLOOD LEVELS OBTAINED AFTER SINGLE AND MULTIPLE DOSES OF ERYTHROMYCIN ESTOLATE AND ERYTHROMYCIN STEARATE. | 1964 | Am. J. Med. Sci. | pmid:14106882 |
| FISCHER HW and HOAK JC | MIMICRY OF ACUTE CHOLECYSTITIS BY ERYTHROMYCIN ESTOLATE REACTIONS. REPORT OF 2 CASES. | 1964 | Am. J. Med. Sci. | pmid:14130320 |
| Martell R et al. | The effects of erythromycin in patients treated with cyclosporine. | 1986 | Ann. Intern. Med. | pmid:3963664 |
| McCormack WM et al. | Hepatotoxicity of erythromycin estolate during pregnancy. | 1977 | Antimicrob. Agents Chemother. | pmid:21610 |
| Patamasucon P et al. | Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. | 1981 | Antimicrob. Agents Chemother. | pmid:6975059 |
| Villa P et al. | Toxicity, uptake, and subcellular distribution in rat hepatocytes of roxithromycin, a new semisynthetic macrolide, and erythromycin base. | 1988 | Antimicrob. Agents Chemother. | pmid:3190183 |
| Bérubé D et al. | Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers. | 1988 | Antimicrob. Agents Chemother. | pmid:3142349 |
| Croteau D et al. | Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography. | 1988 | Antimicrob. Agents Chemother. | pmid:3259856 |
| Amacher DE et al. | Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. | 1991 | Antimicrob. Agents Chemother. | pmid:1656856 |
| Resh W and Stoughton RB | Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones. | 1976 | Arch Dermatol | pmid:134675 |
| Zarrabi MH and Rosner F | Rarity of failure of penicillin prophylaxis to prevent postsplenectomy sepsis. | 1986 | Arch. Intern. Med. | pmid:3521520 |
| Saiz Santos S and Montero López L | [Hepatotoxicity from erythromycin estolate]. | 1992 | Aten Primaria | pmid:1467424 |
| Cooksley WG and Powell LW | Erythromycin jaundice: diagnosis by an in vitro challenge test. | 1977 | Aust N Z J Med | pmid:269690 |
| Hosaka S et al. | In vivo evaluation of ocular inserts of hydrogel impregnated with antibiotics for trachoma therapy. | 1983 | Biomaterials | pmid:6640048 |
| Ozawa H et al. | Ocular inserts for controlled release of antibiotics. | 1983 | Biomaterials | pmid:6615978 |
| Pessayre D and Benhamou JP | Hepatotoxicity of erythromycin derivatives. | 1979 | Br Med J | pmid:445081 |
| BROWN AR | TWO CASES OF UNTOWARD REACTION AFTER "ILOSONE". | 1963 | Br Med J | pmid:14067683 |
| Inman WH and Rawson NS | Erythromycin estolate and jaundice. | 1983 | Br Med J (Clin Res Ed) | pmid:6407653 |
| Bellomo-Brandão MA et al. | Use of erythromycin for the treatment of severe chronic constipation in children. | 2003 | Braz. J. Med. Biol. Res. | pmid:14502372 |
| Aleo MD et al. | Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals. | 2017 | Chem. Res. Toxicol. | pmid:28437613 |
| Swayne LC and Kolc J | Erythromycin hepatotoxicity. A rare cause of a false-positive technetium-99m DISIDA study. | 1986 | Clin Nucl Med | pmid:3943237 |
| Breese BB et al. | The treatment of beta hemolytic streptococcal pharyngitis. Comparison of amoxicillin, erythromycin estolate, and penicillin V. | 1977 | Clin Pediatr (Phila) | pmid:403044 |
| Laperrière H and Lefebvre J | Persistence of inclusion conjunctivitis after oral erythromycin therapy. | 1988 | CMAJ | pmid:3179892 |
| Raynes Greenow CH et al. | Antibiotics for ureaplasma in the vagina in pregnancy. | 2011 | Cochrane Database Syst Rev | pmid:21901685 |
| Altunaiji S et al. | Antibiotics for whooping cough (pertussis). | 2005 | Cochrane Database Syst Rev | pmid:15674946 |
| Altunaiji S et al. | Antibiotics for whooping cough (pertussis). | 2007 | Cochrane Database Syst Rev | pmid:17636756 |
| Nadkarni MS et al. | Treatment of acute bacterial infections of the upper respiratory tract. | 1977 | Curr Med Res Opin | pmid:326492 |
| Sorensen EM and Acosta D | Comparison of dantrolene sodium with erythromycin estolate using primary cultures of rat hepatocytes. | 1985 | Drug Chem Toxicol | pmid:4075997 |
| Murphy PJ et al. | Metabolism of propionyl erythromycin lauryl sulfate. I. Fate of the propionyl erythromycin moiety in the rat. | 1975 May-Jun | Drug Metab. Dispos. | pmid:238814 |
| Murphy PJ et al. | Metabolism of propionyl erythromycin lauryl sulfate. II. Fate of the lauryl sulfate moiety in the rat and man. | 1975 May-Jun | Drug Metab. Dispos. | pmid:238815 |
| Simmen HP et al. | [Erythromycin]. | 1982 | Dtsch. Med. Wochenschr. | pmid:7117164 |
| Lavoie JP et al. | Equine proliferative enteropathy: a cause of weight loss, colic, diarrhoea and hypoproteinaemia in foals on three breeding farms in Canada. | 2000 | Equine Vet. J. | pmid:11037264 |
| Adam D and Scholz H | Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group. | 1996 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:8922570 |
| Scholz H and Noack R | Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group. | 1998 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:9764549 |
| Lu X et al. | Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in rat. | 2014 | Food Chem. Toxicol. | pmid:24412560 |
| Gilbert FI | Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. 1962. | 1995 | Hawaii Med J | pmid:7642362 |
| FLEISCHL H | Effect of erythromycin estolate after unsuccessful malaria-penicillin therapy for general paresis. | 1963 | J Am Geriatr Soc | pmid:13945473 |
| Murugan P and Pari L | Effect of tetrahydrocurcumin on erythromycin estolate-induced lipid peroxidation in rats. | 2005 | J Basic Clin Physiol Pharmacol | pmid:16187483 |
| DiSanto AR et al. | Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets. | 1980 | J Clin Pharmacol | pmid:7430412 |
| Park SJ and Kim SH | Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique. | 2004 | J Colloid Interface Sci | pmid:14972610 |
| Bocka JJ | Pertussis in an infant. | 1989 Jul-Aug | J Emerg Med | pmid:2689510 |
| Venkateswaran S et al. | Protective effect of Livex, a herbal formulation against erythromycin estolate induced hepatotoxicity in rats. | 1997 | J Ethnopharmacol | pmid:9292408 |
| Cachet T et al. | Analysis of erythromycin estolate by liquid chromatography. | 1992 Oct-Dec | J Pharm Biomed Anal | pmid:1298393 |
| Welling PG et al. | Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate. | 1979 | J Pharm Sci | pmid:423080 |
| Stubbs C and Kanfer I | Variability in the absorption and disposition of erythromycin estolate in humans. | 1989 | J Pharm Sci | pmid:2778669 |
| Selenke WM et al. | Nonantibiotic effects of macrolide antibiotics of the oleandomycin-erythromycin group with special reference to their "steroid-sparing" effects. | 1980 | J. Allergy Clin. Immunol. | pmid:6966289 |
| Villa P et al. | Effects of a new fluorinated macrolide (P-0501A) and other erythromycins on drug metabolizing enzymes in rat liver. | 1986 | J. Antibiot. | pmid:3084433 |